Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clostridium Enterocolitis”

48 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 48 results

Post-approval studies (Phase 4)WithdrawnNCT05077085
What this trial is testing

Bezlotoxumab Versus FMT for Multiple Recurrent CDI

Who this might be right for
Clostridium InfectionsClostridioides DifficileEnterocolitis, Pseudomembranous
Leiden University Medical Center
Large-scale testing (Phase 3)Ended earlyNCT00466635
What this trial is testing

Assess the Safety, Tolerability, Effectiveness and Absorption of Exodif™ Tablets in Clostridium Difficile-associated Diarrhea

Who this might be right for
Enterocolitis, PseudomembranousDiarrheaClostridium Difficile
Genzyme, a Sanofi Company 65
Post-approval studies (Phase 4)Not Yet RecruitingNCT07240649
What this trial is testing

Outcomes From Hyperbaric Oxygen (HBO2) Treatment for Emerging Indications

Who this might be right for
Post-COVID-19 ConditionUlcerative ColitisCrohn Disease+38 more
Jay C. Buckey Jr. 100
Large-scale testing (Phase 3)Study completedNCT00182429
What this trial is testing

Efficacy of Metronidazole Versus Metronidazole and Rifampin in CDAD Treatment

Who this might be right for
Clostridium EnterocolitisAntibiotic-Associated DiarrheaPseudomembranous Colitis+2 more
McMaster University 100
Not applicableWithdrawnNCT02968511
What this trial is testing

EGESTA - Emergent GI Therapy for Severe, Complicated CDI Using Fecal Microbiota Transplant

Who this might be right for
C.Difficile Colitis
Milton S. Hershey Medical Center
Testing effectiveness (Phase 2)Study completedNCT02299570
What this trial is testing

Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection

Who this might be right for
Enterocolitis Clostridium Difficile Recurrent
Rebiotix Inc. 150
Not applicableStudy completedNCT00304408
What this trial is testing

Association Between Response to Treatment of C. Diff Colitis and Anti-C.Diff Toxin Antibody

Who this might be right for
Clostridium EnterocolitisPseudomembranous ColitisAntibiotic-Associated Colitis
Michael E. DeBakey VA Medical Center 10
Not applicableEnded earlyNCT01441271
What this trial is testing

Optimal Surgical Treatment Of Fulminant Clostridium Difficile Colitis

Who this might be right for
Clostridium Difficile Colitis
Massachusetts General Hospital 1
Not applicableStudy completedNCT03848689
What this trial is testing

FQ Restriction for the Prevention of CDI

Who this might be right for
Clostridium DifficileClostridium Difficile InfectionC Difficile Colitis
University of Wisconsin, Madison 5,871
Not applicableLooking for participantsNCT04014413
What this trial is testing

Safety and Efficacy of Fecal Microbiota Transplantation

Who this might be right for
Crohn DiseaseUlcerative ColitisCeliac Disease+24 more
Chinese University of Hong Kong 450
Early research (Phase 1)Study completedNCT01551004
What this trial is testing

Phase I Trial of a Single Dose of CRS3123

Who this might be right for
Clostridium Difficile Colitis
National Institute of Allergy and Infectious Diseases (NIAID) 40
Not applicableStudy completedNCT02444624
What this trial is testing

Clostridium and Neonatal Necrotizing Enterocolitis Pathophysiology : Clinical and Molecular Approaches

Who this might be right for
Necrotizing Enterocolitis
Nantes University Hospital 170
Post-approval studies (Phase 4)WithdrawnNCT00304863
What this trial is testing

Addition of Lactobacillus to Metronidazole in Treatment of CDAD

Who this might be right for
EnterocolitisPseudomembranous ColitisAntibiotic-associated Colitis
Michael E. DeBakey VA Medical Center
Large-scale testing (Phase 3)Study completedNCT05831189
What this trial is testing

A Multi-center, Single-arm Trial Exploring the Safety and Clinical Effectiveness of RBX2660 Administered by Colonoscopy to Adults With Recurrent Clostridioides Difficile Infection

Who this might be right for
Clostridium Difficile Infection Recurrence
Ferring Pharmaceuticals 41
Testing effectiveness (Phase 2)Study completedNCT03806803
What this trial is testing

Multicentre Blinded Comparison of Lyophilized Sterile Fecal Filtrate to Lyophilized Fecal Microbiota Transplant in Recurrent Clostridioides Difficile Infection

Who this might be right for
Clostridia Difficile ColitisClostridium Difficile Diarrhea
University of Alberta 138
Large-scale testing (Phase 3)Study completedNCT02254811
What this trial is testing

FMT Delivered by Capsule Versus Colonoscopy for Recurrent C. Diff

Who this might be right for
Enterocolitis Clostridium Difficile Recurrent
University of Alberta 116
Not applicableStudy completedNCT01058356
What this trial is testing

Effect of Probiotic Lactobacilli (Lacidofil Cap®) for the Prevention of Antibiotic-Associated Diarrhea

Who this might be right for
Antibiotics Associated ColitisPulmonary Infection
Pharmbio Korea Co., Ltd. 214
Testing effectiveness (Phase 2)Study completedNCT03427229
What this trial is testing

Fecal Microbiota Transplantation for Severe Clostridium Difficile Infection

Who this might be right for
Clostridium DifficilePseudomembranous Colitis
Catholic University of the Sacred Heart 58
Testing effectiveness (Phase 2)Looking for participantsNCT04305769
What this trial is testing

Alanyl-glutamine Supplementation for C. Difficile Treatment (ACT)

Who this might be right for
Clostridioides Difficile InfectionClostridium Difficile InfectionClostridium Difficile Diarrhea+1 more
University of Virginia 260
Testing effectiveness (Phase 2)Study completedNCT01230957
What this trial is testing

Study of Different Formulations of a Clostridium Difficile Toxoid Vaccine Given at Three Different Schedules in Adults

Who this might be right for
Clostridium Difficile InfectionDiarrhea
Sanofi Pasteur, a Sanofi Company 650
Load More Results